These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26624274)

  • 1. Detection of Novel Genomic Markers for Predicting Prognosis in Hepatocellular Carcinoma Patients by Integrative Analysis of Copy Number Aberrations and Gene Expression Profiles: Results from a Long-Term Follow-Up.
    Cho HJ; Kim SS; Wang HJ; Kim BW; Cho H; Jung J; Cho SS; Kim JK; Lee JH; Kim YB; Yang MJ; Yoo BM; Lee KJ; Cho SW; Cheong JY
    DNA Cell Biol; 2016 Feb; 35(2):71-80. PubMed ID: 26624274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copy Number Aberrations of Multiple Genes Identified as Prognostic Markers for Extrahepatic Metastasis-free Survival of Patients with Hepatocellular Carcinoma.
    Zhu ZZ; Bao LL; Zhao K; Xu Q; Zhu JY; Zhu KX; Wen BJ; Ye YQ; Wan XX; Wang LL; He SQ; Cong WM
    Curr Med Sci; 2019 Oct; 39(5):759-765. PubMed ID: 31612394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.
    Lee SJ; Lee J; Sohn I; Mao M; Kai W; Park CK; Lim HY
    Anticancer Res; 2013 Nov; 33(11):5179-86. PubMed ID: 24222167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Panel of Genes Identified as Targets for 8q24.13-24.3 Gain Contributing to Unfavorable Overall Survival in Patients with Hepatocellular Carcinoma.
    Zhao K; Zhao Y; Zhu JY; Dong H; Cong WM; Yu Y; Wang H; Zhu ZZ; Xu Q
    Curr Med Sci; 2018 Aug; 38(4):590-596. PubMed ID: 30128866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Copy number aberrations of genes related to extrohepatic metastasis-free survival after operation for hepatocellular carcinoma].
    Bao LL; Zhu ZZ; Wen BJ; Wan XX; Ye YQ; Chen L; He SQ; Cong WM
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):349-353. PubMed ID: 28763841
    [No Abstract]   [Full Text] [Related]  

  • 6. Progenitor cell markers predict outcome of patients with hepatocellular carcinoma beyond Milan criteria undergoing liver transplantation.
    Miltiadous O; Sia D; Hoshida Y; Fiel MI; Harrington AN; Thung SN; Tan PS; Dong H; Revill K; Chang CY; Roayaie S; Byrne TJ; Mazzaferro V; Rakela J; Florman S; Schwartz M; Llovet JM
    J Hepatol; 2015 Dec; 63(6):1368-77. PubMed ID: 26220754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
    Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
    Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Association of chromosome 17q copy number variation with overall survival of patients with hepatocellular carcinoma and screening of potential target genes].
    Zhang J; Wen B; Cong W; Chen L; Jiang J; Pan W; He J; Zhu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Oct; 32(5):615-9. PubMed ID: 26418977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss at 16q22.1 identified as a risk factor for intrahepatic recurrence in hepatocellular carcinoma and screening of differentially expressed genes.
    Chen L; Zhu ZZ; Liu SF; Wan X; Wen BJ; Jiang H; Zhu J; Cong WM
    Neoplasma; 2016; 63(1):114-20. PubMed ID: 26639241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of liver kinase B1 predicts poor prognosis in hepatocellular carcinoma.
    Tan X; Liao Z; Liang H; Chen X; Zhang B; Chu L
    Int J Oncol; 2018 Nov; 53(5):1913-1926. PubMed ID: 30226588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of early-stage hepatocellular carcinoma using OncoScan chromosomal copy number aberration data.
    Yu MC; Lee CW; Lee YS; Lian JH; Tsai CL; Liu YP; Wu CH; Tsai CN
    World J Gastroenterol; 2017 Nov; 23(44):7818-7829. PubMed ID: 29209123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-expression of LASS2 and TGF-β1 predicts poor prognosis in hepatocellular carcinoma.
    Ruan H; Wang T; Yang C; Jin G; Gu D; Deng X; Wang C; Qin W; Jin H
    Sci Rep; 2016 Sep; 6():32421. PubMed ID: 27581744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype.
    Kwon SM; Kim DS; Won NH; Park SJ; Chwae YJ; Kang HC; Lee SH; Baik EJ; Thorgeirsson SS; Woo HG
    Carcinogenesis; 2013 Jul; 34(7):1543-50. PubMed ID: 23508637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting the prognosis of hepatocellular carcinoma using gene expression.
    Chang SH; Suh KS; Yi NJ; Lee KH; Kim BY; Jang JJ
    J Surg Res; 2011 Dec; 171(2):524-31. PubMed ID: 20828739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.
    Lim HY; Sohn I; Deng S; Lee J; Jung SH; Mao M; Xu J; Wang K; Shi S; Joh JW; Choi YL; Park CK
    Ann Surg Oncol; 2013 Nov; 20(12):3747-53. PubMed ID: 23800896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression analysis of THOP1 in background liver, a prognostic predictive factor in hepatocellular carcinoma, extracted by multiarray analysis.
    Nomoto S; Hishida M; Inokawa Y; Takano N; Kanda M; Nishikawa Y; Fujii T; Koike M; Sugimoto H; Kodera Y
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S443-50. PubMed ID: 24604581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
    Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
    World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINE-1 methylation level and patient prognosis in a database of 208 hepatocellular carcinomas.
    Harada K; Baba Y; Ishimoto T; Chikamoto A; Kosumi K; Hayashi H; Nitta H; Hashimoto D; Beppu T; Baba H
    Ann Surg Oncol; 2015 Apr; 22(4):1280-7. PubMed ID: 25319577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of combined TGF-β1 and ELF in hepatocellular carcinoma.
    Ji F; Fu SJ; Shen SL; Zhang LJ; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2015 Mar; 15():116. PubMed ID: 25880619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.